ConvaTec Group Plc CTEC.L · Stock Open ConvaTec Group Plc in new tab
ConvaTec Group Plc Analysis (CTEC.L)
Is ConvaTec Group Plc a good investment? ConvaTec Group Plc (CTEC.L) is currently trading at 225.40 GBX. Market analysts have a consensus price target of 296.14 GBX. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 38.13. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: ConvaTec Group Plc is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 0.17.
For income investors, ConvaTec Group Plc pays a dividend yield of 2.35%. With a payout ratio of 78%, the dividend appears to be under pressure.
Investor FAQ
Does ConvaTec Group Plc pay a dividend?
Yes, it pays an annual dividend of 0.07 GBX (2.35% yield).
What asset class is ConvaTec Group Plc?
ConvaTec Group Plc is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 0.06.
Company Profile
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
| Year | Total Dividends |
|---|---|
| ▸2027 |
4.12 GBX
|
| May 28, 2027 (estimated) | 4.1211 |
| ▸2026 |
5.43 GBX
|
| Oct. 1, 2026 (estimated) | 1.4607 |
| May 28, 2026 | 3.9730 |
| ▸2025 |
5.04 GBX
|
| Oct. 1, 2025 | 1.3990 |
| May 29, 2025 | 3.6390 |
| ▸2024 |
4.94 GBX
|
| Oct. 4, 2024 | 1.4220 |
| May 23, 2024 | 3.5174 |
| ▸2023 |
5.04 GBX
|
| Sept. 28, 2023 | 1.3800 |
| May 25, 2023 | 3.6570 |
| ▸2022 |
4.57 GBX
|
| Oct. 6, 2022 | 1.4096 |
| May 19, 2022 | 3.1610 |
| ▸2021 |
4.07 GBX
|
| Oct. 14, 2021 | 1.2290 |
| May 13, 2021 | 2.8450 |
| ▸2020 |
4.40 GBX
|
| Oct. 15, 2020 | 1.3057 |
| May 14, 2020 | 3.0948 |
| ▸2019 |
4.50 GBX
|
| Oct. 17, 2019 | 1.4039 |
| May 16, 2019 | 3.0972 |
| ▸2018 |
4.40 GBX
|
| Oct. 12, 2018 | 1.3087 |
| May 17, 2018 | 3.0935 |
| ▸2017 |
1.06 GBX
|
| Oct. 20, 2017 | 1.0606 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| ConvaTec Group Plc | May 28, 2026 | Paid | 3.973 GBX |
| ConvaTec Group Plc | Oct 01, 2025 | Paid | 1.399 GBX |
Community Discussion